BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barrenschee M, Zorenkov D, Böttner M, Lange C, Cossais F, Scharf AB, Deuschl G, Schneider SA, Ellrichmann M, Fritscher-Ravens A, Wedel T. Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease. Acta Neuropathol Commun 2017;5:1. [PMID: 28057070 DOI: 10.1186/s40478-016-0408-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Leclair-visonneau L, Clairembault T, Volteau C, Chapelet G, Le Dily S, Vavasseur F, Coron E, Préterre C, Neunlist M, Péréon Y, Derkinderen P. Colonic neuropathology is not associated with autonomic dysfunction in Parkinson's disease. Parkinsonism & Related Disorders 2019;61:224-7. [DOI: 10.1016/j.parkreldis.2018.09.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Endres K, Schäfer KH. Influence of Commensal Microbiota on the Enteric Nervous System and Its Role in Neurodegenerative Diseases. J Innate Immun 2018;10:172-80. [PMID: 29742516 DOI: 10.1159/000488629] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
3 Kuzkina A, Schulmeyer L, Monoranu C, Volkmann J, Sommer C, Doppler K. The aggregation state of α-synuclein deposits in dermal nerve fibers of patients with Parkinson's disease resembles that in the brain. Parkinsonism & Related Disorders 2019;64:66-72. [DOI: 10.1016/j.parkreldis.2019.03.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
4 Corbillé AG, Preterre C, Rolli-Derkinderen M, Coron E, Neunlist M, Lebouvier T, Derkinderen P. Biochemical analysis of α-synuclein extracted from control and Parkinson's disease colonic biopsies. Neurosci Lett 2017;641:81-6. [PMID: 28126589 DOI: 10.1016/j.neulet.2017.01.050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
5 Schaeffer E, Kluge A, Böttner M, Zunke F, Cossais F, Berg D, Arnold P. Alpha Synuclein Connects the Gut-Brain Axis in Parkinson's Disease Patients - A View on Clinical Aspects, Cellular Pathology and Analytical Methodology. Front Cell Dev Biol 2020;8:573696. [PMID: 33015066 DOI: 10.3389/fcell.2020.573696] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
6 Lionnet A, Wade MA, Corbillé AG, Prigent A, Paillusson S, Tasselli M, Gonzales J, Durieu E, Rolli-Derkinderen M, Coron E, Duchalais E, Neunlist M, Perkinton MS, Hanger DP, Noble W, Derkinderen P. Characterisation of tau in the human and rodent enteric nervous system under physiological conditions and in tauopathy. Acta Neuropathol Commun 2018;6:65. [PMID: 30037345 DOI: 10.1186/s40478-018-0568-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
7 Martinez-Valbuena I, Amat-Villegas I, Valenti-Azcarate R, Carmona-Abellan MDM, Marcilla I, Tuñon MT, Luquin MR. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies. Acta Neuropathol 2018;135:877-86. [PMID: 29536165 DOI: 10.1007/s00401-018-1832-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
8 Bu J, Liu J, Liu K, Wang Z. Diagnostic utility of gut α-synuclein in Parkinson's disease: A systematic review and meta-analysis. Behav Brain Res 2019;364:340-7. [PMID: 30802532 DOI: 10.1016/j.bbr.2019.02.039] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
9 Derkinderen P, Cossais F, de Guilhem de Lataillade A, Leclair-Visonneau L, Neunlist M, Paillusson S, De Giorgio R. Gastrointestinal mucosal biopsies in Parkinson's disease: beyond alpha-synuclein detection. J Neural Transm (Vienna) 2021. [PMID: 34816335 DOI: 10.1007/s00702-021-02445-6] [Reference Citation Analysis]
10 Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, Mazmanian SK, Volpicelli-Daley LA, Gradinaru V. Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci 2020;23:327-36. [PMID: 32066981 DOI: 10.1038/s41593-020-0589-7] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 36.0] [Reference Citation Analysis]
11 Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, Sandoval IM, Patterson JR, O'Mara A, Yonkers R, Kordower JH. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis 2018;112:106-18. [PMID: 29341898 DOI: 10.1016/j.nbd.2018.01.008] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 16.8] [Reference Citation Analysis]
12 Su X, Fischer DL, Li X, Bankiewicz K, Sortwell CE, Federoff HJ. Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models. Mol Ther 2017;25:2231-5. [PMID: 28522034 DOI: 10.1016/j.ymthe.2017.04.018] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
13 Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Rev Gastroenterol Hepatol 2020;17:673-85. [PMID: 32737460 DOI: 10.1038/s41575-020-0339-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
14 Bindas AJ, Kulkarni S, Koppes RA, Koppes AN. Parkinson's disease and the gut: Models of an emerging relationship. Acta Biomater 2021:S1742-7061(21)00229-4. [PMID: 33857691 DOI: 10.1016/j.actbio.2021.03.071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
15 Rani L, Mondal AC. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications. Neurosci Res 2021;168:100-12. [PMID: 33417973 DOI: 10.1016/j.neures.2021.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Shannon K, Vanden Berghe P. The enteric nervous system in PD: gateway, bystander victim, or source of solutions. Cell Tissue Res 2018;373:313-26. [PMID: 29936550 DOI: 10.1007/s00441-018-2856-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
17 Jan A, Gonçalves NP, Vaegter CB, Jensen PH, Ferreira N. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses. Int J Mol Sci 2021;22:8338. [PMID: 34361100 DOI: 10.3390/ijms22158338] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P. Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis. Trends Neurosci 2019;42:4-13. [PMID: 30342839 DOI: 10.1016/j.tins.2018.09.007] [Cited by in Crossref: 116] [Cited by in F6Publishing: 110] [Article Influence: 29.0] [Reference Citation Analysis]
19 Metzger JM, Emborg ME. Autonomic dysfunction in Parkinson disease and animal models. Clin Auton Res 2019;29:397-414. [PMID: 30604165 DOI: 10.1007/s10286-018-00584-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
20 Cossais F, Schaeffer E, Heinzel S, Zimmermann J, Niesler B, Röth R, Rappold G, Scharf A, Zorenkov D, Lange C, Barrenschee M, Margraf NG, Ellrichmann M, Berg D, Böttner M, Wedel T. Expression Profiling of Rectal Biopsies Suggests Altered Enteric Neuropathological Traits in Parkinson's Disease Patients. J Parkinsons Dis 2021;11:171-6. [PMID: 33337386 DOI: 10.3233/JPD-202258] [Reference Citation Analysis]
21 Killinger BA, Labrie V. Vertebrate food products as a potential source of prion-like α-synuclein. NPJ Parkinsons Dis 2017;3:33. [PMID: 29184902 DOI: 10.1038/s41531-017-0035-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
22 Santos SF, de Oliveira HL, Yamada ES, Neves BC, Pereira A Jr. The Gut and Parkinson's Disease-A Bidirectional Pathway. Front Neurol 2019;10:574. [PMID: 31214110 DOI: 10.3389/fneur.2019.00574] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 17.0] [Reference Citation Analysis]
23 Ganguly U, Singh S, Pal S, Prasad S, Agrawal BK, Saini RV, Chakrabarti S. Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough. Front Aging Neurosci 2021;13:702639. [PMID: 34305577 DOI: 10.3389/fnagi.2021.702639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Mozaffari S, Nikfar S, Daniali M, Abdollahi M. The pharmacological management of constipation in patients with Parkinson's disease: a much-needed relief. Expert Opin Pharmacother 2020;21:701-7. [PMID: 32037901 DOI: 10.1080/14656566.2020.1726319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Guo T, Chen L. Gut microbiota and inflammation in Parkinson’s disease: Pathogenetic and therapeutic insights. Eur J Inflamm 2022;20:1721727X2210837. [DOI: 10.1177/1721727x221083763] [Reference Citation Analysis]
26 Chiang HL, Lin CH. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease. J Mov Disord 2019;12:67-83. [PMID: 31158941 DOI: 10.14802/jmd.18067] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
27 Timmermans JP. Need for more holistic therapeutic and management strategies to understand the causal or correlative link of the Aβ amyloid pathway with Alzheimer's disease for a more efficiënt treatment. Peptides 2018;102:75-7. [PMID: 29524561 DOI: 10.1016/j.peptides.2018.03.002] [Reference Citation Analysis]
28 Killinger BA, Madaj Z, Sikora JW, Rey N, Haas AJ, Vepa Y, Lindqvist D, Chen H, Thomas PM, Brundin P, Brundin L, Labrie V. The vermiform appendix impacts the risk of developing Parkinson's disease. Sci Transl Med 2018;10:eaar5280. [PMID: 30381408 DOI: 10.1126/scitranslmed.aar5280] [Cited by in Crossref: 101] [Cited by in F6Publishing: 100] [Article Influence: 33.7] [Reference Citation Analysis]
29 Tsukita K, Sakamaki-Tsukita H, Tanaka K, Suenaga T, Takahashi R. Value of in vivo α-synuclein deposits in Parkinson's disease: A systematic review and meta-analysis. Mov Disord 2019;34:1452-63. [PMID: 31322768 DOI: 10.1002/mds.27794] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
30 Chen Y, Hou Y, Ge R, Han J, Xu J, Chen J, Wang H. Protective effect of roscovitine against rotenone-induced parkinsonism. Restor Neurol Neurosci 2018;36:629-38. [PMID: 30056439 DOI: 10.3233/RNN-180817] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
31 Menozzi E, Macnaughtan J, Schapira AHV. The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance. Ann Med 2021;53:611-25. [PMID: 33860738 DOI: 10.1080/07853890.2021.1890330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Litvinenko IV, Krasakov IV, Bisaga GN, Skulyabin DI, Poltavsky ID. [Modern conception of the pathogenesis of neurodegenerative diseases and therapeutic strategy]. Zh Nevrol Psikhiatr Im S S Korsakova 2017;117:3-10. [PMID: 28980606 DOI: 10.17116/jnevro2017117623-10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Brás IC, Dominguez-Meijide A, Gerhardt E, Koss D, Lázaro DF, Santos PI, Vasili E, Xylaki M, Outeiro TF. Synucleinopathies: Where we are and where we need to go. J Neurochem 2020;153:433-54. [PMID: 31957016 DOI: 10.1111/jnc.14965] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
34 Murros KE, Huynh VA, Takala TM, Saris PEJ. Desulfovibrio Bacteria Are Associated With Parkinson's Disease. Front Cell Infect Microbiol 2021;11:652617. [PMID: 34012926 DOI: 10.3389/fcimb.2021.652617] [Reference Citation Analysis]
35 Fang X. Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis. Metab Brain Dis 2018;33:1031-43. [PMID: 29681010 DOI: 10.1007/s11011-018-0239-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
36 Deidda G, Biazzo M. Gut and Brain: Investigating Physiological and Pathological Interactions Between Microbiota and Brain to Gain New Therapeutic Avenues for Brain Diseases. Front Neurosci 2021;15:753915. [PMID: 34712115 DOI: 10.3389/fnins.2021.753915] [Reference Citation Analysis]
37 Ma LY, Liu GL, Wang DX, Zhang MM, Kou WY, Feng T. Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease. ACS Chem Neurosci 2019;10:812-23. [PMID: 30714719 DOI: 10.1021/acschemneuro.8b00383] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
38 Fenyi A, Leclair-visonneau L, Clairembault T, Coron E, Neunlist M, Melki R, Derkinderen P, Bousset L. Detection of alpha-synuclein aggregates in gastrointestinal biopsies by protein misfolding cyclic amplification. Neurobiology of Disease 2019;129:38-43. [DOI: 10.1016/j.nbd.2019.05.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
39 Gorecki AM, Anyaegbu CC, Anderton RS. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut. Transl Neurodegener 2021;10:47. [PMID: 34814947 DOI: 10.1186/s40035-021-00271-0] [Reference Citation Analysis]
40 Zheng Y, Yu Z, Zhao J, Cai H, Wang Z, Wang X, Feng T. Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease. Front Aging Neurosci 2022;14:867528. [DOI: 10.3389/fnagi.2022.867528] [Reference Citation Analysis]
41 Villumsen M, Aznar S, Pakkenberg B, Jess T, Brudek T. Inflammatory bowel disease increases the risk of Parkinson’s disease: a Danish nationwide cohort study 1977–2014. Gut 2018;68:18-24. [DOI: 10.1136/gutjnl-2017-315666] [Cited by in Crossref: 102] [Cited by in F6Publishing: 95] [Article Influence: 25.5] [Reference Citation Analysis]
42 Sorrentino ZA, Giasson BI, Chakrabarty P. α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease. Acta Neuropathol 2019;138:1-21. [PMID: 30798354 DOI: 10.1007/s00401-019-01977-2] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 14.3] [Reference Citation Analysis]
43 Tan JSY, Chao YX, Rötzschke O, Tan EK. New Insights into Immune-Mediated Mechanisms in Parkinson's Disease. Int J Mol Sci 2020;21:E9302. [PMID: 33291304 DOI: 10.3390/ijms21239302] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Wakabayashi K. Where and how alpha-synuclein pathology spreads in Parkinson's disease. Neuropathology 2020;40:415-25. [PMID: 32750743 DOI: 10.1111/neup.12691] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
45 Butkovich LM, Houser MC, Tansey MG. α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson's Disease Pathogenesis. Front Neurosci 2018;12:626. [PMID: 30258347 DOI: 10.3389/fnins.2018.00626] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
46 Orimo S, Ghebremedhin E, Gelpi E. Peripheral and central autonomic nervous system: does the sympathetic or parasympathetic nervous system bear the brunt of the pathology during the course of sporadic PD? Cell Tissue Res 2018;373:267-86. [PMID: 29869180 DOI: 10.1007/s00441-018-2851-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
47 Gazerani P. Probiotics for Parkinson's Disease. Int J Mol Sci 2019;20:E4121. [PMID: 31450864 DOI: 10.3390/ijms20174121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
48 Yoon SY, Heo SJ, Kim YW, Yang SN, Moon HI. Ankylosing Spondylitis: A Risk Factor for Parkinsonism-A Nationwide Population-Based Study. J Parkinsons Dis 2021. [PMID: 34602503 DOI: 10.3233/JPD-212878] [Reference Citation Analysis]